Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Front Neuroendocrinol. 2022 Dec 25;68:101051. doi: 10.1016/j.yfrne.2022.101051

Table 4.

Neurotransmitter/Neuropeptide/Biochemical assay results summary

SYSTEM PATHWAY UPREGULATION (# OF STUDIES) DOWNREGULATION (# OF STUDIES) NO SIGNIFICANT EFFECTS (# OF STUDIES) UPREGULATION AND DOWNREGULATION (# OF STUDIES)
DOPAMINERGIC 1(Ponzio et al., 1977) 6 (Chaudhuri et al., 1992; Dey et al., 1991; Jori & Dolfini, 1976; Marchi & Cugurra, 1974; Shetty & Gaitonde, 1980b; Simone et al., 2015) 1 (Algeri et al., 1976)
CHOLINERGIC 2 (Daabees et al., 1981; Ladinsky et al., 1976) 1 (Bandyopadhyay & Ghosh, 1988)
LIPID PATHWAYS 1 (Islam et al., 1980)
BETA-ENDORPHIN 2 (Tejwani et al., 1985; Tejwani et al., 1983)
BDNF 1 (Simone et al., 2015)
GABA 3 (Porcu et al., 2012; Rao et al., 1984; Shetty & Gaitonde, 1980a) 1(Sassoè-Pognetto et al., 2007) 1 (Daabees et al., 1981)
SEROTONIN 1 (Daabees et al., 1981)